All sites C00-96,D32-33,D42-43,D45-47,D76 443 88.1 3.5 3.6 0.5 4.3
Mouth, pharynx C00-14 6 100.0 - - - -
  Lip C00 0 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 86 74.5 5.3 10.6 1.2 8.3
  Oesophagus C15 3 100.0 - - - -
  Stomach C16 10 96.1 - - 2.0 2.0
  Small intestine C17 1 100.0 - - - -
  Colon C18 24 95.9 - 2.5 0.8 0.8
  Rectum, rectosigmoid C19-20 16 98.8 - - - 1.2
  Anus C21 1 100.0 - - - -
  Liver C22 4 50.0 10.0 20.0 - 20.0
  Gallbladder, bile ducts C23-24 7 47.1 14.7 11.8 2.9 23.5
  Pancreas C25 20 26.3 16.2 35.4 2.0 20.2
  Other digestive organs C26 0 50.0 - - - 50.0
Respiratory organs C30-39 22 66.1 18.8 12.5 - 2.7
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 22 65.7 19.4 12.0 - 2.8
  Mediastinum, pleura C38 0 50.0 - 50.0 - -
Bone C40-41 1 80.0 - 20.0 - -
Melanoma of the skin C43 15 100.0 - - - -
Skin, non-melanoma C44 25 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 123 99.5 0.2 0.3 - -
Female genital organs C51-58 57 95.1 3.1 - 0.3 1.4
  Cervix uteri C53 5 96.2 - - 3.8 -
  Corpus uteri C54 29 97.9 0.7 - - 1.4
  Uterus, other C55,C58 0 - - - - 100.0
  Ovary C56 14 88.6 11.4 - - -
  Other female genital C51-52,C57 9 97.8 - - - 2.2
Urinary organs C64-68 19 93.5 - 1.1 1.1 4.3
  Kidney C64 10 90.0 - 2.0 2.0 6.0
  Bladder and urinary tract2 C65-68 9 97.7 - - - 2.3
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 16 83.5 - 5.1 1.3 10.1
Thyroid gland C73 10 98.0 - - 2.0 -
Other endocrine glands C74-75 1 100.0 - - - -
Illdefined or unknown C76,C80 11 55.6 16.7 13.0 3.7 11.1
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 48 77.4 5.9 2.1 0.4 14.2
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 23 98.2 0.9 - - 0.9
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 5 48.0 16.0 20.0 - 16.0
  Leukaemia C91-95 7 44.1 14.7 - 2.9 38.2
  Myelodysplastic syndromes D46 3 7.7 15.4 - - 76.9
  Myeloproliferaitive neoplasms D45,D47 8 78.9 5.3 - - 15.8
Not included above
  Carcinoma in situ of the breast D05 12 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 43 100.0 - - - -
  Borderline tumour of the ovary D39 6 90.0 - - - 10.0
  Basal cell carcinoma of the skin 173 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.